Source: Sleep and Breathing Conference 2021



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hedner (Göteborg, Sweden). From the laboratory to the bedside: the pharmacotherapy of obstructive sleep apnoea. Sleep and Breathing Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Pre-operative screening for obstructive sleep apnoea Source: Eur Respir Rev 2017; 26: 160012 Year: 2017 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Telemedicine(TM)-based strategy for management of obstructive sleep apnea (OSA): Virtual sleep unit Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Validation of a new polygraphy device for the diagnosis of obstructive sleep apnoea (OSA) Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment Source: Eur Respir Rev, 26 (146) 170069; 10.1183/16000617.0069-2017 Year: 2017 A comparison of laboratory polysomnography and a home sleep study in the diagnosis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Screening for sleep-disordered breathing Year: 2010 Advances in the surgical treatment of obstructive sleep apnoea Source: International Congress 2017 – Multidisciplinary management of sleep apnoea Year: 2017 Challenges and perspectives in obstructive sleep apnoea Source: Eur Respir J, 52 (3) 1702616; 10.1183/13993003.02616-2017 Year: 2018 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 Diagnosis of obstructive sleep apnoea in children: standards for sleep study duration Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Does auto-CPAP improve the quality of sleep in obstructive sleep apnoea (OSA)? Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001 Screening for obstructive sleep apnoea in professional drivers Source: Breathe, 16 (1) 29364; 10.1183/20734735.0364-2019 Year: 2020 Implementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndrome Source: ERJ Open Res, 6 (3) 00362-2019; 10.1183/23120541.00362-2019 Year: 2020 Cardiovascular disorders in children with obstructive sleep apnea Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005